Quoin Pharmaceuticals
QNRX
2 hedge funds and large institutions have $949K invested in Quoin Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
232% more capital invested
Capital invested by funds: $285K → $949K (+$664K)
100% more funds holding
Funds holding: 1 → 2 (+1)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$231K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$57.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWA
Arkadios Wealth Advisors
Atlanta,
Georgia
|
-$441 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $868K | +$231K | +4 | +44% |
|
|
2
UBS Group
Zurich,
Switzerland
| $54K | +$57.7K | +1 | New |
|
3
Morgan Stanley
New York
| $25K | – | – | – |
|
4
Citigroup
New York
| $1K | – | – | – |
|
|
PA
5
Procyon Advisors
Shelton,
Connecticut
| $1K | – | – | – |
|
|
AWA
6
Arkadios Wealth Advisors
Atlanta,
Georgia
| – | -$441 | – | – |
|
QNRX Hedge Fund Activity: Q2 2020 in Review
2 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q2 2020, worth a combined $949K — up 232% from $285K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new QNRX positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $231K. The largest seller was Arkadios Wealth Advisors, cutting an estimated $441.
- 2 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q2 2020, up from 1 in Q1 2020.
- Funds reported $949K of Quoin Pharmaceuticals stock for Q2 2020, up 232% quarter-over-quarter.
- 1 fund opened new Quoin Pharmaceuticals positions in Q2 2020 and 0 closed out, a net change of +1 holder.
- The largest Quoin Pharmaceuticals buyer in Q2 2020 was Renaissance Technologies, an estimated $231K added.
- The largest Quoin Pharmaceuticals seller in Q2 2020 was Arkadios Wealth Advisors, an estimated $441 sold.
Based on aggregated 13F filings for Q2 2020.